LetterOne
LetterOne is a Luxembourgish investment company. It was founded in 2013 by Mikhail Fridman.
- Founded
- 2013
- Founded by
- Mikhail Fridman
- Headquarters
- Luxembourg
- Industry
- investment
- Country
- Luxembourg
All 8 facts, and where they come from
Facts
8 facts · 0 confirmed by two sources · 0 cited · 8 from one source
Where this comes from
Papalocal keeps its own record. It started from these sources; what each one said is kept here as it was copied, so a change on their side never changes this page by itself. Tap one to read its version.
What Wikidata says · copied November 17, 2026 · revision 2292891538
- Described as
- Luxembourgish investment company
- What it is
- business
- Founded
- 2013
- Founded by
- Mikhail Fridman · 1 reference
- Headquarters
- Luxembourg
- Country
- Luxembourg
- Industry
- investment · 1 reference
- Owned by
- Mikhail Fridman
- Official website
- https://www.letterone.lu/
- Wikipedias with a page
- 7
Wikidata item Q20182134 (wikidata.org/wiki/Q20182134), public domain (CC0). Copied 2026-11-17.
What Wikipedia says · copied November 17, 2026 · revision 1375740383
LetterOne Holdings S.A. (LetterOne) is an international investment business based in Luxembourg. With long-term investments in the telecoms, technology, healthcare, and energy sectors, the firm has four main units: L1 Health, L1 Technology, L1 Retail, and L1 Energy, all of which are supported by L1 Treasury Services, which manages the group's liquidity. LetterOne was set up LetterOne in 2013 as part of a broader new investment vehicle using the proceeds from the sale of TNK-BP. LetterOne had $26.8 billion in equity at the end of 2021. Co-founders Mikhail Fridman and Petr Aven stepped down from the company in early March 2022, after the EU imposed sanctions on them in the wake of the Russian invasion of Ukraine. The board now includes Mervyn Davies, Jonathan Muir, Franz Humer, Richard R. Burt, and Wulf von Schimmelmann, with Davies serving as chairman and Muir as CEO. Among major investments in 2023 were Turkcell, Qvantel, VEON, Wintershall Dea, DIA and Holland & Barrett.
From the Wikipedia article “LetterOne” (en.wikipedia.org/wiki/LetterOne), by its contributors, under CC BY-SA 4.0 (creativecommons.org/licenses/by-sa/4.0/). Copied 2026-11-17; not changed.
Confirmed Two sources agree. Cited One source, and it names where it got it. One source One source, without a reference of its own. Sources disagree The sources disagree. We show the best-supported value and keep theirs below.
